Caffeine as a Therapy for Parkinson's Disease

NCT01738178 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

119

Enrollment

OTHER

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: Caffeine
DRUG: Placebo

Sponsor

McGill University Health Centre/Research Institute of the McGill University Health Centre

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]